obinutuzumab

Ukraine

Drugs containing this active substance

  • GAZIVA

    The drug is used for the treatment of adults with chronic lymphocytic leukemia (in combination with chlorambucil), as well as for the treatment of patients with follicular lymphoma (both in combination with chemotherapy and as maintenance therapy).

    Form: concentrate for infusion solution

    Active substance Dosage
    obinutuzumab 25 mg/ml

    ATC: L01FA03

    Manufacturer: F. Hoffmann-La Roche Ltd (batch release; secondary packaging)